CMND

Clearmind Medicine Inc. Common Shares

$3.58 +46.12%

Recent alerts on CMND

All signals →

SEC filing CMND Receives Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial

SEC filing CMND Announces 1-for-10 Reverse Share Split to Regain Nasdaq Compliance, Reducing Shares to 1,019,033

SEC filing CMND Partners with Hebrew University to Study MEAI with Tirzepatide, Targets $170B Incretin Therapies Market

SEC filing CMND Reaches Milestone with 20 Participants Treated in Phase I/IIa Trial

Short interest Short interest 276.5% of float

SEC filing CMND Files European Patent for PTSD Psychedelic Compounds, Targets $18.5B Market, Aligns with Trump Psychedelic Order

Short interest Short interest 293.5% of float

SEC filing CMND Reports $0 Revenue, $0 EPS, No Deals, Vancouver HQ, BC Canada, Foreign Issuer, SEC 6-K, April 2026, 001-41557, 101-1220 W 6th Ave

SEC filing CMND Announces President Trump’s Executive Order Accelerating Psychedelic Therapies for PTSD, Alcohol Use Disorder, Veteran Mental Health, FDA Breakthrough Designation, MEAI Named in H.R. 7091, Phase I/IIa Trials at Yale, Johns Hopkins

SEC filing CMND Reports $0 Revenue, $0 EPS, No Deals, Vancouver HQ, BC Canada, Foreign Issuer, SEC 6-K, April 2026, 001-41557, 101-1220 W 6th Ave

SEC filing CMND Reports $0 Revenue, $0 EPS, Files 6-K for April 2026

SEC filing CMND Reports CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Trial for Alcohol Use Disorder Vancouver, Canada, April 14, 2026

SEC filing CMND Announces Patent Publication for MEAI-PEA Weight Loss & MASLD Therapy, Targeting $226B Market by 2035

SEC filing CMND Advances CMND-100 Phase I/IIa Trial to Third Cohort After DSMB Approval, 80mg Dose, Multinational Sites Including Johns Hopkins, Tel Aviv, Hadassah, Non-Hallucinogenic Neuroplastogen for Alcohol Use Disorder, Favorable Safety Profile, No Serious Adverse Events, Full Treatmen

SEC filing CMND Partners with Polyrizon to Develop Intranasal MEAI Formulation for Addiction Disorders

Short volume Short volume 81% of volume (3.7σ)

Scanner Large move: up 3560.8% (80.3x typical daily range)

Failures to deliver 4,184,008 shares failed to deliver

Failures to deliver 5,993,117 shares failed to deliver

Get push alerts for CMND

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS